chrisgarand
Joined 10 years ago
Joined 10 years ago
SpaceX will be re-valued on Anthropic's, or OpenAI's success, he, and his people are smart enough to understand this.
Network gets swipe fees, and a percentage of the interchange Issuers get majority of interchange, and carrying interest and fees Acquirer gets the markup plus whatever admin/maintenance fees
Here's what I found for a reference: https://cmspi.com/back-to-basics-card-network-models-and-glo... which tracks with my experience.
I'm open to be corrected though.
I don't know if it works, but I've always had a consistent level of token burn on my plans (I've only heavily used Sol after adding it).
I read that they're trying to cross breed modern corn with one from Oaxaca that has this relationship: https://news.wisc.edu/corn-that-acquires-its-own-nitrogen-id...
You want to disable "Switch models when a message is flagged"[1]
[1] https://support.claude.com/en/articles/16049681-why-claude-s...
They generally looks for the doodles on older chips, but also looks at MEMs devices as well: https://www.youtube.com/@EvilmonkeyzDesignz
They would definitely be able to add to the list (they have a video of 100 chips for their 100k subscriber mark).
The NIH Revitalization Act of 1993 was supposed to bring women back into medical research. The reality was that women were always included, HOWEVER in 1977,(1) because of the outcomes from thalidomide (causing birth defects), "women of childbearing potential" were excluded from the phase 1, and early phase 2 trials (the highest risk trials). They're still generally generally excluded, even after the passage of the act. This was/is to protect the women, and potential children.
According to Edward E. Bartlett in his meta data analysis from 2001, men have been routinely under-represented in NIH data (even before adjusting for men's mortality rates) between 1966-1990. (2)
There's also routinely twice as much spent every year on women's health studies vs men's by the NIH. (3)
It makes sense to me, but I'm biased. Logically, since men lead in 9 of the top 10 causes for death, that shows there's something missing in the equation of research. (4 - It's not a straight forward table, you can view the total deaths, and causes and compare the two for men, and women)
With that being said, it doesn't tell us about the quality of the funding or research topics, maybe the money is going towards pointless goals, or unproductive researchers.
Are there gaps in research? Most definitely, like women who are pregnant. This is put in place to avoid harm but that doesn't help them when they fall into them. Are there more? Definitely. I'm not educated enough in the nuances to go into them.
If you have information that counters what I've posted, please share it, I would love know where these folks are blind so I can take a look at my bias.
(1) https://petrieflom.law.harvard.edu/2021/04/16/pregnant-clini... (2) https://journals.lww.com/epidem/fulltext/2001/09000/did_medi... (3) https://jameslnuzzo.substack.com/p/nih-funding-of-mens-and-w... < I spot checked a couple of the figures, and those lined up. I'm assuming the rest is accurate (4) https://www.cdc.gov/womens-health/lcod/index.html#:~:text=Ov...
I agree with your point, having a second, impartial source is important to confirm the ballpark.
Here are things to consider:
Experienced builders don't care about the takeoffs on a big picture basis, the takeoffs are usually wrong, even if perfectly done. In our experience half of drawings we receive, are heavily revised by the order is approved (heavily revised meaning over 10% has changed). EWP, structural metal need to be accurate but framing lumber, and sheet good can be off on counts at the lift quantity (+-1 lift for an average house).
Suppliers aren't responsible for the takeoff so the amount the quote is negligible (see drawing revisions, and trades can misallocate the materials - This can't be reasonably traced). Over? The customer ends up paying less, under? The customer pays more. This has been universal where I am (Ontario, Canada).
A large minority of plans are missing key elements (like sheer walls), pointing out, and showing these differences would be a big value add for the consumer (contractors using the materials) by the supplier.
Good customers understand that lumber is a commodity, a lower price this week can flip next week, and they'll contact their preferred vendor about the differences.
There's always a preferred vendor.
Not great customers will shoot drawing off to multiple suppliers, causing them all to do the same takeoff, wasting time, and money, only to deal with the same issues above. They'll still go back to their preferred vendor to get the lowest price.
Summary of the above is: EWP, and structural metal are key items because they rarely change, framing lumber, and sheathing requirements change all the time. What you're looking at is helping suppliers capture the bad customers (which are often the biggest, to be clear), but saving suppliers the time handling them is great. Also, accuracy, and pricing isn't that important (with caveats).
This isn't a statistically significant sample size, consider it anecdotal.
Their biggest issue is that they focus on too many products, and interoperability between them. Necessary features take forever to be implemented years after they should have been.
From the values of each, you can tell that multi-family units are a larger portion of residential construction. How much larger would require more research as on a per unit basis, multi-family units are cheaper per family than a single-family unit.
Essentially, manufactured home in this case, even if they were 50% of single-family home construction, would be less than 25% of total family units constructed (single-family units + (singe units being construction in multi-family buildings).
Mono-embryonic seeds are not true to type, which means their seeds will not grow fruit like their parent tree. Techniques like grafting, air layering, and cloning were developed to quickly scale editable fruiting types. They reduce the risk of having a plant that is non-productive, and accelerates the anticipated fruiting period vs from seed (most tree types will be 8-15 years before fruiting, while a clone can produce in as little as 3 years, but generally no longer than 5).
I've been going over avocado seeds to find proof of poly embryonic types as these: https://academic.oup.com/jhered/article-abstract/35/7/209/81...
Information for avocado's seems to be lacking, I have a quick reference for which citrus can/will grow true to type, however with avocado's, there is some research, but few points of use for home growers. If there's anyone that can point me to a good resource, I would appreciate it!
That being said, you can probably use a smaller amount of instant yeast, it definitely shouldn't be replaced as a 1:1 with regular yeast as the fermentation time is an integral part of the flavour profile.
When he was talking about neoclouds, he was talking about the smaller guys who are getting bullied by vendors (mainly Nvidia) to buy as much hardware as possible (more than they want to). They paid more, for more, and needed to take on more debt, to end up (currently anyways) being well below capacity.
Over the next few years, unless growth keeps up (and probably accelerates), they'll need to sell, or restructure.
The buildouts by Microsoft, Google, Meta, OpenAI, and Anthropic are currently safe. The neoclouds that they've signed contracts with, are safe, but based on reports, that's roughly 60% of current capacity (it varies by report, but they're all under 75%).